annual net income:
-$88.88M+$137.66M(+60.77%)Summary
- As of today (May 29, 2025), BCRX annual net profit is -$88.88 million, with the most recent change of +$137.66 million (+60.77%) on December 31, 2024.
- During the last 3 years, BCRX annual net income has risen by +$95.18 million (+51.71%).
- BCRX annual net income is now -1751.69% below its all-time high of -$4.80 million, reached on December 31, 1998.
Performance
BCRX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$32.00K+$26.83M(+100.12%)Summary
- As of today (May 29, 2025), BCRX quarterly net profit is $32.00 thousand, with the most recent change of +$26.83 million (+100.12%) on March 31, 2025.
- Over the past year, BCRX quarterly net income has increased by +$35.41 million (+100.09%).
- BCRX quarterly net income is now -99.79% below its all-time high of $15.15 million, reached on December 31, 2009.
Performance
BCRX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$53.47M+$35.41M(+39.84%)Summary
- As of today (May 29, 2025), BCRX TTM net profit is -$53.47 million, with the most recent change of +$35.41 million (+39.84%) on March 31, 2025.
- Over the past year, BCRX TTM net income has increased by +$155.12 million (+74.37%).
- BCRX TTM net income is now -3464.67% below its all-time high of -$1.50 million, reached on June 30, 1999.
Performance
BCRX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BCRX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.8% | +100.1% | +74.4% |
| 3 y3 years | +51.7% | +100.0% | +72.4% |
| 5 y5 years | +18.4% | +100.1% | +53.7% |
BCRX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.0% | at high | +100.0% | at high | +78.4% |
| 5 y | 5-year | at high | +64.0% | at high | +100.0% | at high | +78.4% |
| alltime | all time | -1751.7% | +64.0% | -99.8% | +100.0% | -3464.7% | +78.4% |
BCRX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $32.00K(-100.1%) | -$53.47M(-39.8%) |
| Dec 2024 | -$88.88M(-60.8%) | -$26.80M(+90.9%) | -$88.88M(-28.2%) |
| Sep 2024 | - | -$14.03M(+10.7%) | -$123.82M(-15.2%) |
| Jun 2024 | - | -$12.67M(-64.2%) | -$145.93M(-30.0%) |
| Mar 2024 | - | -$35.38M(-42.7%) | -$208.59M(-7.9%) |
| Dec 2023 | -$226.54M(-8.3%) | -$61.73M(+70.8%) | -$226.54M(-4.2%) |
| Sep 2023 | - | -$36.15M(-52.0%) | -$236.35M(-2.6%) |
| Jun 2023 | - | -$75.33M(+41.2%) | -$242.72M(+7.3%) |
| Mar 2023 | - | -$53.33M(-25.5%) | -$226.25M(-8.4%) |
| Dec 2022 | -$247.12M(+34.3%) | -$71.54M(+68.3%) | -$247.12M(+27.8%) |
| Sep 2022 | - | -$42.52M(-27.8%) | -$193.35M(-7.8%) |
| Jun 2022 | - | -$58.86M(-20.7%) | -$209.63M(+8.1%) |
| Mar 2022 | - | -$74.20M(+317.3%) | -$193.97M(+5.4%) |
| Dec 2021 | -$184.06M(+0.7%) | -$17.78M(-69.8%) | -$184.06M(-18.8%) |
| Sep 2021 | - | -$58.80M(+36.1%) | -$226.78M(+5.9%) |
| Jun 2021 | - | -$43.20M(-32.8%) | -$214.09M(+2.2%) |
| Mar 2021 | - | -$64.28M(+6.3%) | -$209.50M(+14.6%) |
| Dec 2020 | -$182.81M(+67.9%) | -$60.49M(+31.2%) | -$182.81M(+46.3%) |
| Sep 2020 | - | -$46.12M(+19.4%) | -$124.94M(+7.3%) |
| Jun 2020 | - | -$38.61M(+2.7%) | -$116.42M(+0.8%) |
| Mar 2020 | - | -$37.60M(+1334.0%) | -$115.44M(+6.0%) |
| Dec 2019 | -$108.90M(+7.6%) | -$2.62M(-93.0%) | -$108.90M(-18.6%) |
| Sep 2019 | - | -$37.59M(-0.1%) | -$133.71M(+6.4%) |
| Jun 2019 | - | -$37.63M(+21.2%) | -$125.71M(+18.0%) |
| Mar 2019 | - | -$31.05M(+13.2%) | -$106.53M(+5.2%) |
| Dec 2018 | -$101.25M(+53.9%) | -$27.43M(-7.3%) | -$101.25M(+8.4%) |
| Sep 2018 | - | -$29.60M(+60.5%) | -$93.36M(+18.3%) |
| Jun 2018 | - | -$18.45M(-28.4%) | -$78.90M(+2.0%) |
| Mar 2018 | - | -$25.78M(+31.9%) | -$77.34M(+17.6%) |
| Dec 2017 | -$65.78M(+19.3%) | -$19.54M(+29.1%) | -$65.78M(+29.6%) |
| Sep 2017 | - | -$15.13M(-10.4%) | -$50.74M(+7.7%) |
| Jun 2017 | - | -$16.89M(+18.8%) | -$47.14M(+1.3%) |
| Mar 2017 | - | -$14.22M(+215.8%) | -$46.53M(-15.6%) |
| Dec 2016 | -$55.14M(+28.2%) | -$4.50M(-60.9%) | -$55.14M(-19.8%) |
| Sep 2016 | - | -$11.53M(-29.2%) | -$68.78M(-4.3%) |
| Jun 2016 | - | -$16.28M(-28.7%) | -$71.87M(+41.8%) |
| Mar 2016 | - | -$22.83M(+25.9%) | -$50.69M(+17.8%) |
| Dec 2015 | -$43.02M(-4.8%) | -$18.14M(+24.0%) | -$43.02M(+17.7%) |
| Sep 2015 | - | -$14.62M(-398.3%) | -$36.56M(+19.2%) |
| Jun 2015 | - | $4.90M(-132.3%) | -$30.67M(-38.9%) |
| Mar 2015 | - | -$15.16M(+29.9%) | -$50.22M(+11.1%) |
| Dec 2014 | -$45.19M(+50.1%) | -$11.67M(+33.7%) | -$45.19M(+16.0%) |
| Sep 2014 | - | -$8.73M(-40.4%) | -$38.95M(+1.9%) |
| Jun 2014 | - | -$14.65M(+44.5%) | -$38.22M(+6.9%) |
| Mar 2014 | - | -$10.14M(+86.7%) | -$35.74M(+18.7%) |
| Dec 2013 | -$30.11M(-23.0%) | -$5.43M(-32.1%) | -$30.11M(-15.7%) |
| Sep 2013 | - | -$8.00M(-34.3%) | -$35.73M(-4.5%) |
| Jun 2013 | - | -$12.17M(+170.1%) | -$37.43M(-0.3%) |
| Mar 2013 | - | -$4.51M(-59.2%) | -$37.53M(-4.0%) |
| Dec 2012 | -$39.08M(-31.4%) | -$11.05M(+13.9%) | -$39.08M(-5.2%) |
| Sep 2012 | - | -$9.70M(-21.0%) | -$41.22M(-10.4%) |
| Jun 2012 | - | -$12.28M(+102.8%) | -$45.98M(-8.0%) |
| Mar 2012 | - | -$6.05M(-54.1%) | -$49.97M(-12.2%) |
| Dec 2011 | -$56.95M(+68.2%) | -$13.19M(-8.8%) | -$56.95M(+5.5%) |
| Sep 2011 | - | -$14.46M(-11.1%) | -$53.96M(+7.1%) |
| Jun 2011 | - | -$16.27M(+24.9%) | -$50.36M(+13.7%) |
| Mar 2011 | - | -$13.03M(+27.7%) | -$44.28M(+30.8%) |
| Dec 2010 | -$33.85M(+151.7%) | -$10.20M(-6.1%) | -$33.85M(+298.2%) |
| Sep 2010 | - | -$10.86M(+6.6%) | -$8.50M(+2.9%) |
| Jun 2010 | - | -$10.19M(+292.8%) | -$8.26M(+22.3%) |
| Mar 2010 | - | -$2.60M(-117.1%) | -$6.75M(-49.8%) |
| Dec 2009 | -$13.45M | $15.15M(-242.6%) | -$13.45M(-27.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.63M(+22.4%) | -$18.53M(+9.7%) |
| Jun 2009 | - | -$8.68M(-6.5%) | -$16.90M(-19.2%) |
| Mar 2009 | - | -$9.29M(-192.3%) | -$20.93M(-15.4%) |
| Dec 2008 | -$24.73M(-14.9%) | $10.07M(-212.0%) | -$24.73M(-33.3%) |
| Sep 2008 | - | -$8.99M(-29.2%) | -$37.09M(-5.1%) |
| Jun 2008 | - | -$12.71M(-3.0%) | -$39.07M(+17.2%) |
| Mar 2008 | - | -$13.10M(+473.6%) | -$33.33M(+14.7%) |
| Dec 2007 | -$29.06M(-33.4%) | -$2.28M(-79.2%) | -$29.06M(-21.1%) |
| Sep 2007 | - | -$10.98M(+57.7%) | -$36.82M(-11.1%) |
| Jun 2007 | - | -$6.96M(-21.1%) | -$41.44M(-7.0%) |
| Mar 2007 | - | -$8.82M(-12.2%) | -$44.56M(+2.2%) |
| Dec 2006 | -$43.62M(+67.1%) | -$10.05M(-35.6%) | -$43.62M(+7.1%) |
| Sep 2006 | - | -$15.60M(+54.7%) | -$40.73M(+24.3%) |
| Jun 2006 | - | -$10.08M(+27.9%) | -$32.77M(+15.7%) |
| Mar 2006 | - | -$7.88M(+10.1%) | -$28.34M(+8.6%) |
| Dec 2005 | -$26.10M(+23.7%) | -$7.16M(-6.3%) | -$26.10M(+7.7%) |
| Sep 2005 | - | -$7.64M(+35.4%) | -$24.23M(+10.7%) |
| Jun 2005 | - | -$5.65M(+0.1%) | -$21.88M(+2.8%) |
| Mar 2005 | - | -$5.64M(+6.7%) | -$21.29M(+0.9%) |
| Dec 2004 | -$21.10M(+66.2%) | -$5.29M(-0.1%) | -$21.10M(+10.7%) |
| Sep 2004 | - | -$5.30M(+4.7%) | -$19.07M(+11.0%) |
| Jun 2004 | - | -$5.06M(-7.4%) | -$17.18M(+11.7%) |
| Mar 2004 | - | -$5.46M(+68.1%) | -$15.37M(+21.1%) |
| Dec 2003 | -$12.70M(-25.0%) | -$3.25M(-4.7%) | -$12.70M(+4.2%) |
| Sep 2003 | - | -$3.41M(+4.8%) | -$12.18M(-0.0%) |
| Jun 2003 | - | -$3.25M(+16.6%) | -$12.19M(-13.5%) |
| Mar 2003 | - | -$2.79M(+1.9%) | -$14.10M(-16.7%) |
| Dec 2002 | -$16.93M(+239.5%) | -$2.74M(-19.9%) | -$16.93M(-11.7%) |
| Sep 2002 | - | -$3.42M(-33.8%) | -$19.17M(+25.0%) |
| Jun 2002 | - | -$5.16M(-8.1%) | -$15.34M(+66.4%) |
| Mar 2002 | - | -$5.62M(+12.8%) | -$9.22M(+84.9%) |
| Dec 2001 | -$4.99M(-56.9%) | -$4.98M(-1293.8%) | -$4.99M(+169.5%) |
| Sep 2001 | - | $417.00K(-56.5%) | -$1.85M(-43.0%) |
| Jun 2001 | - | $958.00K(-169.3%) | -$3.25M(-41.4%) |
| Mar 2001 | - | -$1.38M(-24.9%) | -$5.54M(-52.2%) |
| Dec 2000 | -$11.58M(+118.4%) | -$1.84M(+87.9%) | -$11.58M(+14.2%) |
| Sep 2000 | - | -$980.00K(-26.4%) | -$10.14M(-10.7%) |
| Jun 2000 | - | -$1.33M(-82.1%) | -$11.36M(+10.0%) |
| Mar 2000 | - | -$7.42M(+1756.0%) | -$10.32M(+94.8%) |
| Dec 1999 | -$5.30M(+10.4%) | -$400.00K(-81.8%) | -$5.30M(-17.2%) |
| Sep 1999 | - | -$2.20M(+633.3%) | -$6.40M(+326.7%) |
| Jun 1999 | - | -$300.00K(-87.5%) | -$1.50M(-64.3%) |
| Mar 1999 | - | -$2.40M(+60.0%) | -$4.20M(-12.5%) |
| Dec 1998 | -$4.80M(-54.7%) | -$1.50M(-155.6%) | -$4.80M(-22.6%) |
| Sep 1998 | - | $2.70M(-190.0%) | -$6.20M(-45.6%) |
| Jun 1998 | - | -$3.00M(0.0%) | -$11.40M(+8.6%) |
| Mar 1998 | - | -$3.00M(+3.4%) | -$10.50M(-0.9%) |
| Dec 1997 | -$10.60M(+37.7%) | -$2.90M(+16.0%) | -$10.60M(+8.2%) |
| Sep 1997 | - | -$2.50M(+19.0%) | -$9.80M(0.0%) |
| Jun 1997 | - | -$2.10M(-32.3%) | -$9.80M(+10.1%) |
| Mar 1997 | - | -$3.10M(+47.6%) | -$8.90M(+15.6%) |
| Dec 1996 | -$7.70M(-10.5%) | -$2.10M(-16.0%) | -$7.70M(-1.3%) |
| Sep 1996 | - | -$2.50M(+108.3%) | -$7.80M(+8.3%) |
| Jun 1996 | - | -$1.20M(-36.8%) | -$7.20M(-5.3%) |
| Mar 1996 | - | -$1.90M(-13.6%) | -$7.60M(-11.6%) |
| Dec 1995 | -$8.60M(+24.6%) | -$2.20M(+15.8%) | -$8.60M(+4.9%) |
| Sep 1995 | - | -$1.90M(+18.8%) | -$8.20M(+3.8%) |
| Jun 1995 | - | -$1.60M(-44.8%) | -$7.90M(-3.7%) |
| Mar 1995 | - | -$2.90M(+61.1%) | -$8.20M(+18.8%) |
| Dec 1994 | -$6.90M | -$1.80M(+12.5%) | -$6.90M(+35.3%) |
| Sep 1994 | - | -$1.60M(-15.8%) | -$5.10M(+45.7%) |
| Jun 1994 | - | -$1.90M(+18.8%) | -$3.50M(+118.8%) |
| Mar 1994 | - | -$1.60M | -$1.60M |
FAQ
- What is BioCryst Pharmaceuticals annual net profit?
- What is the all time high annual net income for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual net income year-on-year change?
- What is BioCryst Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly net income year-on-year change?
- What is BioCryst Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM net income year-on-year change?
What is BioCryst Pharmaceuticals annual net profit?
The current annual net income of BCRX is -$88.88M
What is the all time high annual net income for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual net profit is -$4.80M
What is BioCryst Pharmaceuticals annual net income year-on-year change?
Over the past year, BCRX annual net profit has changed by +$137.66M (+60.77%)
What is BioCryst Pharmaceuticals quarterly net profit?
The current quarterly net income of BCRX is $32.00K
What is the all time high quarterly net income for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly net profit is $15.15M
What is BioCryst Pharmaceuticals quarterly net income year-on-year change?
Over the past year, BCRX quarterly net profit has changed by +$35.41M (+100.09%)
What is BioCryst Pharmaceuticals TTM net profit?
The current TTM net income of BCRX is -$53.47M
What is the all time high TTM net income for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM net profit is -$1.50M
What is BioCryst Pharmaceuticals TTM net income year-on-year change?
Over the past year, BCRX TTM net profit has changed by +$155.12M (+74.37%)